NextCure, Inc. Banner Image

NextCure, Inc.

  • Ticker NXTC
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
NextCure, Inc. Logo Image
  • 51-200 Employees
  • Based in Beltsville, Maryland
NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases. Through their proprietary FIND-IO™ platform, they study various immune cells to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicinesMore. Their initial focus is to bring hope and new treatments to patients who do not respond to current cancer therapies, patients whose cancer progresses despite treatment and patients with cancer types not adequately addressed by available therapies.
4.8 / 5.0 (188)

NextCure, Inc. reports have an aggregate usefulness score of 4.8 based on 188 reviews.

NextCure, Inc.

Most Recent Annual Report

NextCure, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

NextCure, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!